https://endpts.com/vistagens-positive-phiii-for-social-anxiety-nasal-spray-pushes-stock-price-up-1000/
0
0
8/7/23 at 6:26pm
Organization
Endpoints News
Author
Zachary Brennan
San Francisco-based Vistagen saw its stock soar more than 1,000% at one point on Monday after unveiling positive topline results from a Phase III trial showing its nasal spray helped adults with social anxiety disorder. The Phase III PALISADE-2 trial of 140 s…
Create an account
or login to join the discussion